2012-11-16 - Female - 16 Years old
481720
| Adverse reaction report number | 481720 |
| Latest AER version number | 0 |
| Market authorization holder AER number | ALL1201205541 |
| Initial received date | 2012-11-16 |
| Latest received date | 2012-11-16 |
| Age | 16 Years |
| Gender | Female |
| Weight | N/A |
| Type of report | Study |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | MAH |
| Report outcome | Unknown |
| Serious report? | Yes |
Reason for seriousness
| Death | |
| Disability | |
| Cogenital anomaly | |
| Life threateting | |
| Hospitalization | |
| Other medically important | Yes |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 10 Milligram | 1 every 1 Day(s) | Product used for unknown indication |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Anxiety | |
| Fatigue | |
| Flat affect | |
| Headache | |
| Heart rate increased | |
| Palpitations | |
| Peripheral coldness | |